Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Agent Delays Pre-term Labor in Rats

By HospiMedica staff writers
Posted on 29 Aug 2005
A clinical trial has shown that mixed oxytocin (OT)-vasopressin receptor antagonist atosiban exhibited similar efficacy as betablockers in treating pre-term labor in rats, but with markedly lower maternal cardiovascular side effects.

A long-time aim of obstetrical research has been to find agents that could delay or diminish pre-term labor because it is a leading cause of infant mortality and morbidity. More...
In the United States, disorders associated with short gestation and low birth weight accounted for 4,400 or 15.7% of infant deaths in 2002, second only to congenital disorders, which accounted for 5,570 deaths.

There is evidence that OT plays an important role in pre-term labor, especially causing contractions of the myometrial muscles. OT-receptor agonists have been shown to inhibit spontaneous myometrial contractions in vitro and to suppress myometrial activity in live animal models.

"Delaying labor with oxytocin receptor antagonist may significantly reduce infant morbidiy, including lung disease, intraventricular hemorrhage, and possibly even death,” said David P. Brooks, vice president, biology, U.S., GlaxoSmithKline Pharmaceuticals, (GSK, London, UK; www.gsk.com). He explained that GSK researchers have developed a series of nonpeptide selective oxytocin receptor antagonists that have a high affinity for the human and rat OT receptors with a greater than 1,000-fold selectivity over the human
vasopressin receptors. "These compounds suppress spontaneous contractions in late-term (19-21 days) pregnant rats,” he added.






Related Links:
GlaxoSmithKline Pharma

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Multi-Chamber Washer-Disinfector
WD 390
New
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.